The market for novel therapies that treat diseases of the brain, spine and the nerves is rapidly increasing. In conjunction with the Mind Research Network, Lovelace Biomedical builds successful and efficient neurological studies that meet all FDA requirements for IND filings in this key space. Our team’s unmatched understanding of neurophysiology and neuropharmacology allows us to bring great precision to every step of the process.
Development of neuro-behavioral and fMRI endpoints
Delivering titrated doses of neurological agents and neuro-protective agents to dial in effect and maximize therapeutic window
Feedback to formulation scientists on formulation behavior and stability
Large-animal models of traumatic brain injury and traumatic spinal cord injury
Creating new methods when necessary to address scientific hypotheses